The notion that you are what you eat may go back even farther -- to your mother, said a Baylor College of
medicine researcher in a
report that appears in the current issue of the Journal of Molecular Endocrinology.
(Ludwig Institute for Cancer Research) Published today in Nature
medicine, investigators from the Stockholm Branch of the Ludwig Institute for Cancer Research and University of Michigan Medical
School show that toxicity associated with tPA, the most effective treatment currently available to stroke patients, might be overcome if combined with the leukemia drug, imatinib. Imatinib greatly reduced tPA-associated bleeding in mice, and extended the critical window in which tPA can be administered after the stroke had begun by two hours.